觅瑞（Mirxes）拿下泰国癌症早筛，大单！

IVD经销商01-26

请求“星标”，否则收不到推送，谢谢来源：360Dx、 IVD从业者网（纽约路透电）新加坡癌症早筛企业觅瑞（Mirxes）周三宣布与泰国曼谷杜斯特医疗服务集团（BDMS）旗下N Health达成战略合作，将为N Health在泰国近60家医院提供基于微小核糖核酸（miRNA）的癌症筛查检测服务。根据协议，觅瑞将向N Health旗下医院提供包括胃癌检测"觅小卫"（GastroClear）和肺癌检测...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2606429209?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-26 21:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2606429209","market":"hk","top_or_hot":-1,"title":"觅瑞（Mirxes）拿下泰国癌症早筛，大单！","media":"IVD经销商","content":"<div>\n<p>请求“星标”，否则收不到推送，谢谢来源：360Dx、 IVD从业者网（纽约路透电）新加坡癌症早筛企业觅瑞（Mirxes）周三宣布与泰国曼谷杜斯特医疗服务集团（BDMS）旗下N Health达成战略合作，将为N Health在泰国近60家医院提供基于微小核糖核酸（miRNA）的癌症筛查检测服务。根据协议，觅瑞将向N Health旗下医院提供包括胃癌检测\"觅小卫\"（GastroClear）和肺癌检测...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126210940953e6527&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>觅瑞（Mirxes）拿下泰国癌症早筛，大单！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n觅瑞（Mirxes）拿下泰国癌症早筛，大单！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-26 21:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126210940953e6527&s=b><strong>IVD经销商</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>请求“星标”，否则收不到推送，谢谢来源：360Dx、 IVD从业者网（纽约路透电）新加坡癌症早筛企业觅瑞（Mirxes）周三宣布与泰国曼谷杜斯特医疗服务集团（BDMS）旗下N Health达成战略合作，将为N Health在泰国近60家医院提供基于微小核糖核酸（miRNA）的癌症筛查检测服务。根据协议，觅瑞将向N Health旗下医院提供包括胃癌检测\"觅小卫\"（GastroClear）和肺癌检测...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126210940953e6527&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126210940953e6527&s=b","article_id":"2606429209","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126210940953e6527&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606429209","pubTimestamp":1769432471,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"请求“星标”，否则收不到推送，谢谢来源：360Dx、 IVD从业者网新加坡癌症早筛企业觅瑞周三宣布与泰国曼谷杜斯特医疗服务集团旗下N Health达成战略合作，将为N Health在泰国近60家医院提供基于微小核糖核酸的癌症筛查检测服务。根据协议，觅瑞将向N Health旗下医院提供包括胃癌检测\"觅小卫\"和肺癌检测LungClear在内的癌症筛查产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02629":"MIRXES-B"},"translate_title":"Mirxes won early cancer screening in Thailand, a big order!","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":1.5},"content_text":"请求“星标”，否则收不到推送，谢谢来源：360Dx、 IVD从业者网（纽约路透电）新加坡癌症早筛企业觅瑞（Mirxes）周三宣布与泰国曼谷杜斯特医疗服务集团（BDMS）旗下N Health达成战略合作，将为N Health在泰国近60家医院提供基于微小核糖核酸（miRNA）的癌症筛查检测服务。根据协议，觅瑞将向N Health旗下医院提供包括胃癌检测\"觅小卫\"（GastroClear）和肺癌检测LungClear在内的癌症筛查产品。双方未披露具体财务条款。BDMS医院支持业务集团首席执行官兼N Health董事总经理伽拉普·纳隆利表示：\"在泰国迈入老龄化社会之际，此次合作让我们能将先进的癌症风险评估整合到预防性医疗体系中，支持早期干预，推动全民健康老龄化。\"觅瑞同时宣布在泰国推出两款直接面向消费者的居家检测产品：用于结直肠癌筛查的便隐血检测试纸FITRapid，以及胃癌风险因素幽门螺杆菌检测试纸\"Helico Rapid。觅瑞联合创始人兼首席执行官周林汉指出：\"通过将我们的miRNA技术与N Health的临床网络相结合，并通过零售药房渠道推出安全可靠的家用检测产品，我们正在让泰国大众享受到严谨科学的预防性医疗服务，同时也为觅瑞在东南亚的发展铺平道路。\"声明：本文仅代表作者观点，不代表平台立场，如果转载涉及版权等问题，请尽快联系我们，我们第一时间更正或删除，谢谢！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606429209","isCrawlerRequest":true}